Hepatitis A
Hepatitis B
Hepatitis C
Delta Hepatitis
Incubation
2-6 weeks
4 weeks-6 months
Variable: 14-160 days; average, 50 days
Same as hepatitis B
Communicable
Until 7-9 days after jaundice occurs
Several months-as long as virus present in blood
As long as virus present in blood
As long as virus present in blood
Transmission
Fecal-oral; blood; sexual
Parenteral; sexual; perinatal
Percutaneous, via contaminated blood, parenteral drug abuse; some fecal-oral forms; sexual, perinatal
Parenteral; blood
Sources
Crowding; contaminated food, milk, or
Contaminated needles, syringes, surgical instruments
Persons who have received 15 or more blood transfusions; IV drug users; persons traveling to contaminated areas
Contaminated needles, syringes
Portal of entry
GI tract; asymptomatic
Integumentary: blood plasma or transfusions
Blood
Integumentary: blood
HB antigen
Not present
Present
Not present
Present as with hepatitis B
Incidence
Sporadic epidemics;
increased in children
Increased in ages 15-29, particularly in heroin addiction; occupational hazard for laboratory workers, nurses, physicians
All ages groups; higher in adults because of exposure to risk factors
Same as hepatitis B
Immunity
Preexposure:
immune globulin, 0.02 mL/kg
Postexposure:
within 2 weeks of exposure, as above
Preexposure:
hepatitis B vaccine
Postexposure:
immune globulin with high amounts of anti-HBs (HBIG); hepatitis B vaccine
None; immune globulin may be given
Prevention
Hand washing, use of gloves; hepatitis A
vaccine
Care when handling products contaminated by blood, use of gloves;
Hepatitis B vaccine
Same as hepatitis B
Same as hepatitis B
Severity
Mild
Mild to moderate
Mild to moderate
Moderate to severe
Fever
Common
Uncommon
Uncommon
Uncommon
Nausea/ vomiting
Common
Common
Common
Common